ALERT B&C announces awarding of NSERC grant for the development of early warning and response systems

    LAVAL, QC, March 19 /CNW Telbec/ - ALERT B&C Corporation (the
"Corporation") (TSX Venture Exchange: ACB) is pleased to announce that based
on ALERT'S technology the Natural Sciences & Engineering Research Council
(NSERC) has awarded a grant in the amount of $1, 243,260 to a consortium
comprised of the University of Saskatchewan, McGill University, Concordia
University, the Biotechnology Research Institute (NRC), the Montreal
Department of Public Health, UV-Sterisource and ALERT B&C Corporation.
    The basis of the grant is to support the prestigious "Immune Buildings:
Development of eWAR Systems" strategic project. Early Warning and Response
(eWAR) Systems are to be implemented in public buildings. The objective is to
utilize the eWAR systems to monitor buildings in order to detect, identify,
and initiate a first response to chemical and biological agents threats. The
intended control strategy is based on mitigating actions combined into
independent eWAR systems for buildings at risk. During the project, a HVAC
(Heat Ventilation and Air Conditioning) system will be constructed and used
for actual simulations of building contamination. Since the main source of
propagation of chemical and biological agents is through air, eWAR systems are
intended to be used to trigger alarms when an unusual event occurs thereby
initiating a series of remediation procedures. ALERT B&C's TRAKER(TM)
instruments will be used by the system for rapid detection and identification
of harmful agents. The project will provide real field situation for testing
ALERT's TRAKER(TM) and provide important information that will allow the
Corporation to further improve its detection technology.
    "Civilian protection is a broad field that requires the input of several
disciplines and technologies. As such, ALERT B&C is constantly seeking
collaborations as part of its on-going R&D efforts with other groups of
researchers interested in developing tools for first responders involved in
dangerous situations. This eWAR project is an excellent example of such
collaboration," stated Dr. Suzanne L. Lebel, President and Chief Executive
Officer. "We are pleased and honored to be part of this prestigious group and
to have our TRAKER(TM) instruments incorporated into the eWAR project".
    ALERT B&C is involved in the rapid detection and identification of
chemicals and biological substances that can be harmful to civilian
populations. These substances can be released in public areas with wrongful
intents (terrorism) or accidentally (industrial spills, outbreaks). ALERT B&C
is developing a series of instruments such as the TRAKER(TM) that can rapidly
detect and identify chemical and biological compounds in field conditions.
These instruments are based on mass spectrometry and utilize a unique patented
ionization technology, Metastable Atom Bombardment ("MAB"). More recently,
ALERT B&C has expanded the scope of applications of its instruments to cover a
wider base of situations that may affect civilian populations, such as
accidental contamination of water plants and hospitals.

    About the Corporation

    Founded in 1995, the Corporation is a BioDefence company dedicated to
supplying the BioDefence market with high quality technologies, products and
solutions, in order to improve and maintain the safety and the security of
individuals worldwide. For more information about the Corporation visit our
new website at

    This press release contains forward-looking statements, which reflect the
Corporation's current expectations regarding future events. The
forward-looking statements involve risks and uncertainties. Actual events
could differ materially from those projected herein. Investors should consult
the Corporation's quarterly filings and annual reports for additional
information on risks and uncertainties relating to these forward-looking
statements. The reader is cautioned not to rely on these forward-looking
statements. The Corporation disclaims any obligation to update these
forward-looking statements.

    The TSX Venture Exchange does not accept responsibility for the adequacy
    or accuracy of this press release.
    %SEDAR: 00012523EF

For further information:

For further information: Investor relations: Dr. Suzanne L. Lebel,
Chairman, President & CEO, ALERT B&C Corporation, (450) 688-4499, Fax: (450)
688-9100,; Media relations: Jean-Pierre Trudel, President,
Jean-Pierre Trudel & Associates Inc., (514) 347-6111, Fax: (514) 693-1253,

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890